PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 135 filers reported holding PROVENTION BIO INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |